1887

Abstract

is one of the most important opportunistic pathogens involved in nosocomial infections, cystic fibrosis patients included. Hospital isolates frequently present multidrug-resistance (MDR) phenotypes as the consequence of constant antibiotic selective pressure. The kinetics of emergence of MDR mutants under antibiotic selective pressure indicated that long-term incubation in the presence of the bacteriostatic antibiotic tetracycline increases the mutation rate per cell per day of PAO1 by several orders of magnitude. The tetracycline-resistant mutants obtained were stable, showed decreased susceptibility to antibiotics belonging to different structural families, and contained an outer-membrane protein not present in the wild-type strain PAO1. These data are consistent with the hypothesis that incubation in the presence of tetracycline favours the emergence of MDR mutants in . The results are relevant for understanding the rapid emergence of antibiotic-resistant mutants among bacterial populations during infections. Their relationship to other models of increased mutagenesis under stress is discussed with respect to the adaptive mutation phenomenon.

Loading

Article metrics loading...

/content/journal/micro/10.1099/00221287-145-10-2857
1999-10-01
2019-12-08
Loading full text...

Full text loading...

/deliver/fulltext/micro/145/10/1452857a.html?itemId=/content/journal/micro/10.1099/00221287-145-10-2857&mimeType=html&fmt=ahah

References

  1. Atlas, R. M. (1993). Handbook of Microbiological Media. London: CRC Press.
  2. Baquero, F. & Blazquez, J. ( 1997; ). Evolution of antibiotic resistance. Trends Ecol Evol 12, 482-487.[CrossRef]
    [Google Scholar]
  3. Baquero, F., Negri, M. C., Morosini, M. I. & Blazquez, J. ( 1997; ). The antibiotic selective process: concentration-specific amplification of low-level resistant populations. Ciba Found Symp 207, 93-105.
    [Google Scholar]
  4. Bonhoeffer, S., Lipsitch, M. & Levin, B. R. ( 1997; ). Evaluating treatment protocols to prevent antibiotic resistance. Proc Natl Acad Sci USA 94, 12106-12111.[CrossRef]
    [Google Scholar]
  5. Cairns, J. & Foster, P. L. ( 1991; ). Adaptive reversion of a frameshift mutation in Escherichia coli. Genetics 128, 695-701.
    [Google Scholar]
  6. Clerch, B., Barbe, J. & Llagostera, M. ( 1992; ). The role of the excision and error-prone repair systems in mutagenesis by fluorinated quinolones in Salmonella typhimurium. Mutat Res 281, 207-213.[CrossRef]
    [Google Scholar]
  7. Deguchi, T., Kawamura, T., Yasuda, M., Nakano, M., Fukuda, H., Kato, H., Kato, N., Okano, Y. & Kawada, Y. ( 1997; ). In vivo selection of Klebsiella pneumoniae strains with enhanced quinolone resistance during fluoroquinolone treatment of urinary tract infections. Antimicrob Agents Chemother 41, 1609-1611.
    [Google Scholar]
  8. Everett, M. J., Jin, Y. F., Ricci, V. & Piddock, L. J. V. ( 1996; ). Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob Agents Chemother 40, 2380-2386.
    [Google Scholar]
  9. Fukuoka, T., Masuda, N., Takenouchi, T., Sekine, N., Iijima, M. & Ohya, S. ( 1991; ). Increase in susceptibility of Pseudomonas aeruginosa to carbapenem antibiotics in low-amino-acid media. Antimicrob Agents Chemother 35, 529-532.[CrossRef]
    [Google Scholar]
  10. Gottesman, M. M., Hrycyna, C. A., Schoenlein, P. V., Germann, U. A. & Pastan, I. ( 1995; ). Genetic analysis of the multidrug transporter. Annu Rev Genet 29, 607-649.[CrossRef]
    [Google Scholar]
  11. Govan, J. R. & Nelson, J. W. ( 1992; ). Microbiology of lung infection in cystic fibrosis. Br Med Bull 48, 912-930.
    [Google Scholar]
  12. Kanematsu, E., Deguchi, T., Yasuda, M., Kawamura, T., Nishino, Y. & Kawada, Y. ( 1998; ). Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV associated with quinolone resistance in Enterococcus faecalis. Antimicrob Agents Chemother 42, 433-435.
    [Google Scholar]
  13. Kasak, L., Horak, R. & Kivisaar, M. ( 1997; ). Promoter-creating mutations in Pseudomonas putida: a model system for the study of mutation in starving bacteria. Proc Natl Acad Sci USA 94, 3134-3139.[CrossRef]
    [Google Scholar]
  14. Kerem, B., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M. & Tsui, L. C. ( 1989; ). Identification of the cystic fibrosis gene: genetic analysis. Science 245, 1073-1080.[CrossRef]
    [Google Scholar]
  15. Köhler, T., Michea-Hamzehpour, M., Henze, U., Gotoh, N., Curty, L. K. & Pechère, J. C. ( 1997a; ). Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol 23, 345-354.[CrossRef]
    [Google Scholar]
  16. Köhler, T., Michea-Hamzehpour, M., Plesiat, P., Kahr, A. L. & Pechère, J. C. ( 1997b; ). Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa. Antimicrob Agents Chemother 41, 2540-2543.
    [Google Scholar]
  17. McKenzie, G. J., Lombardo, M. J. & Rosenberg, S. M. ( 1998; ). Recombination-dependent mutation in Escherichia coli occurs in stationary phase. Genetics 149, 1163-1165.
    [Google Scholar]
  18. Maenhaut-Michel, G. & Shapiro, J. A. ( 1994; ). The roles of starvation and selective substrates in the emergence of araB-lacZ fusion clones. EMBO J 13, 5229-5239.
    [Google Scholar]
  19. Martı́nez, J. L., Alonso, A., Gómez-Gómez, J. M. & Baquero, F. ( 1998; ). Quinolone resistance by mutations in chromosomal gyrase genes. Just the tip of the iceberg? J Antimicrob Chemother 42, 683-688.[CrossRef]
    [Google Scholar]
  20. Mittler, J. E. & Lenski, R. E. ( 1990; ). New data on excisions of Mu from E. coli MCS2 cast doubt on directed mutation hypothesis. Nature 344, 173-175.[CrossRef]
    [Google Scholar]
  21. National Committee for Clinical Laboratory Standards (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 4th edn. Approved standard M7 A4. Wayne, PA, USA.
  22. Nikaido, H. ( 1994; ). Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264, 382-388.[CrossRef]
    [Google Scholar]
  23. Ostroff, R. M., Wretlind, B. & Vasil, M. L. ( 1989; ). Mutations in the hemolytic-phospholipase C operon result in decreased virulence of Pseudomonas aeruginosa PAO1 grown under phosphate-limiting conditions. Infect Immun 57, 1369-1373.
    [Google Scholar]
  24. Poole, K., Krebes, K., McNally, C. & Neshat, S. ( 1993; ). Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol 175, 7363-7372.
    [Google Scholar]
  25. Poole, K., Gotoh, N., Tsujimoto, H. & 7 other authors ( 1996; ). Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Mol Microbiol 21, 713–724.[CrossRef]
    [Google Scholar]
  26. Quinn, J. P. ( 1998; ). Clinical problems posed by multiresistant nonfermenting gram-negative pathogens. Clin Infect Dis 27, S117-S124.[CrossRef]
    [Google Scholar]
  27. Riesenfeld, C., Everett, M., Piddock, L. J. & Hall, B. G. ( 1997; ). Adaptive mutations produce resistance to ciprofloxacin. Antimicrob Agents Chemother 41, 2059-2060.
    [Google Scholar]
  28. Rosenberg, S. M. ( 1997; ). Mutation for survival. Curr Opin Genet Dev 7, 829-834.[CrossRef]
    [Google Scholar]
  29. Saier, M. H.Jr, Paulsen, I. T., Sliwinski, M. K., Pao, S. S., Skurray, R. A. & Nikaido, H. ( 1998; ). Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria. FASEB J 12, 265-274.
    [Google Scholar]
  30. Sferra, T. J. & Collins, F. S. ( 1993; ). The molecular biology of cystic fibrosis. Annu Rev Med 44, 133-144.[CrossRef]
    [Google Scholar]
  31. Shapiro, J. A. ( 1984; ). Observations on the formation of clones containing araB-lacZ cistron fusions. Mol Gen Genet 194, 79-90.[CrossRef]
    [Google Scholar]
  32. Shapiro, J. A. ( 1993; ). Natural genetic engineering of the bacterial genome. Curr Opin Genet Dev 3, 845-848.[CrossRef]
    [Google Scholar]
  33. Shapiro, J. A. ( 1997; ). Genome organization, natural genetic engineering and adaptive mutation. Trends Genet 13, 98-104.[CrossRef]
    [Google Scholar]
  34. Sniegowski, P. D. ( 1995; ). A test of the directed mutation hypothesis in Escherichia coli MCS2 using replica plating. J Bacteriol 177, 1119-1120.
    [Google Scholar]
  35. Torkelson, J., Harris, R. S., Lombardo, M. J., Nagendran, J., Thulin, C. & Rosenberg, S. M. ( 1997; ). Genome-wide hypermutation in a subpopulation of stationary-phase cells underlies recombination-dependent adaptive mutation. EMBO J 16, 3303-3311.[CrossRef]
    [Google Scholar]
  36. Wang, T., Tanaka, M. & Sato, K. ( 1998; ). Detection of grlA and gyrA mutations in 344 Staphylococcus aureus strains. Antimicrob Agents Chemother 42, 236-240.
    [Google Scholar]
  37. Wiedemann, B. & Heisig, P. ( 1994; ). Mechanisms of quinolone resistance. Infection 22, S73-S79.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/00221287-145-10-2857
Loading
/content/journal/micro/10.1099/00221287-145-10-2857
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error